Ajanta Pharmaceuticals — 100-point case study
How Ajanta Pharmaceuticals looked on 50 technical and 50 fundamental measures on 09 Jul 2026 — and what happened over the next three months. Education only; not a current view.
| Codes | NSE: AJANTPHARM · BSE: 532331 |
|---|---|
| Close on 09 Jul 2026 | ₹3,307.60 |
| Market cap then | ₹41,332 crore |
| Valuation | P/E 39.1× · P/B 9.13× |
| Momentum | RSI (14) 58 · 1-year return +25.9% |
| Next 3 months | +3.1% vs Nifty 50 -6.0% (to 09 Oct 2026) |
Scorecard
Technical — 50 points
25 bullish · 19 neutral · 2 caution · 3 bearish — the picture leaned positive.
Fundamental — 50 points
17 bullish · 28 neutral · 2 caution · 2 bearish — the picture leaned positive.